← Back to the disclosure log

Who in Congress Has Traded Bristol-Myers Squibb Company (BMY)?

The Bristol-Myers Squibb Company line shows up 136 times in the congressional disclosure record between 2013 and 2026, filed by 37 members: 78 purchases against 58 sales. On balance the chamber has been net buyers, and the purchases sit up 28.6% against the latest close.

136Trades
78Buys
58Sells
37Members
$66.82Latest close 2026-10-26
+28.6%Congress buys vs latest close*

*Purchases only, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings report a range, never a share count, so this follows the stock rather than anyone's position size.

57% buys43% sells

How it splits by party

Republicans
47 buys · 44 sells
23 members · 91 trades
Democrats
31 buys · 13 sells
13 members · 44 trades

Whose BMY buys have done best

Members ranked by how their reported BMY purchases have moved since, over roughly the last three years, weighted by disclosed band midpoint and marked to the latest close.

1 Rohit Khanna
+31.9%
2 Alan Armstrong
+14.1%
3 Virginia Foxx
+12.5%
DateMemberTypeAmountEst. priceLatest closeReturn
2019-04-23Gilbert CisnerosBUY$1K–$15K$45.32$66.82 2026-09-04+47.4%
2018-12-28Sheldon WhitehouseSELL$15K–$50K$50.94$66.82 2026-09-04-31.2% exit
2018-11-26John A. YarmuthSELL$1K–$15K$52.73$66.82 2026-09-04-26.7% exit
2018-09-14Mike KellyBUY$1K–$15K$60.69$66.82 2026-09-04+10.1%
2018-06-15Rohit KhannaBUY$1K–$15K$54.80$66.82 2026-09-04+21.9%
2018-06-11Rohit KhannaBUY$1K–$15K$53.12$66.82 2026-09-04+25.8%
2018-06-08Carlos CurbeloSELL$1K–$15K$53.16$66.82 2026-09-04-25.7% exit
2018-06-04James M InhofeSELL$50K–$100K$51.45$66.82 2026-09-04-29.9% exit
2018-05-08James B. RenacciBUY$1K–$15K$50.53$66.82 2026-09-04+32.2%
2018-05-07James B. RenacciBUY$1K–$15K$51.32$66.82 2026-09-04+30.2%
2018-04-06Carlos CurbeloBUY$1K–$15K$60.88$66.82 2026-09-04+9.8%
2018-03-20Lamar SmithSELL$1K–$15K$66.43$66.82 2026-09-04-0.6% exit
2018-02-02George HoldingBUY$1K–$15K$63.48$66.82 2026-09-04+5.3%
2018-01-04Shelley M CapitoSELL$1K–$15K$61.75$66.82 2026-09-04-8.2% exit
2018-01-04Shelley M CapitoSELL$1K–$15K$61.75$66.82 2026-09-04-8.2% exit
2018-01-04Shelley M CapitoSELL$1K–$15K$61.75$66.82 2026-09-04-8.2% exit
2018-01-02Rohit KhannaSELL$15K–$50K$61.31$66.82 2026-09-04-9.0% exit
2017-12-21John A. YarmuthBUY$1K–$15K$61.50$66.82 2026-09-04+8.7%
2017-11-30Rohit KhannaBUY$15K–$50K$63.19$66.82 2026-09-04+5.7%
2017-11-27Rohit KhannaBUY$1K–$15K$61.61$66.82 2026-09-04+8.5%
2017-10-26Shelley M CapitoSELL$1K–$15K$60.95$66.82 2026-09-04-9.6% exit
2017-09-25Denny HeckBUY$1K–$15K$63.19$66.82 2026-09-04+5.7%
2017-09-25Alan S. LowenthalSELL$15K–$50K$63.19$66.82 2026-09-04-5.7% exit
2017-07-27Alan S. LowenthalBUY$15K–$50K$54.24$66.82 2026-09-04+23.2%
2017-07-19James B. RenacciBUY$1K–$15K$55.07$66.82 2026-09-04+21.3%
2017-07-18Rohit KhannaBUY$1K–$15K$54.74$66.82 2026-09-04+22.1%
2017-07-13Sheldon WhitehouseSELL$1K–$15K$54.67$66.82 2026-09-04-22.2% exit
2017-06-15Patty MurraySELL$1K–$15K$54.28$66.82 2026-09-04-23.1% exit
2017-05-16James B. RenacciBUY$1K–$15K$54.39$66.82 2026-09-04+22.9%
2017-04-27Lamar SmithSELL$1K–$15K$55.67$66.82 2026-09-04-20.0% exit
2017-03-28Lamar SmithSELL$1K–$15K$56.20$66.82 2026-09-04-18.9% exit
2017-03-22David A Perdue , JrBUY$1K–$15K$56.36$66.82 2026-09-04+18.6%
2017-03-16Patty MurrayBUY$1K–$15K$57.31$66.82 2026-09-04+16.6%
2017-03-07James B. RenacciBUY$1K–$15K$56.33$66.82 2026-09-04+18.6%
2017-02-28James M InhofeSELL$15K–$50K$56.71$66.82 2026-09-04-17.8% exit
2017-02-28Kurt SchraderBUY$1K–$15K$56.71$66.82 2026-09-04+17.8%
2017-02-23Sheldon WhitehouseBUY$1K–$15K$55.77$61.61 2026-10-26+10.5%
2017-02-08James B. RenacciBUY$1K–$15K$52.00$66.82 2026-09-04+28.5%
2017-02-01James M InhofeBUY$15K–$50K$49.29$66.82 2026-09-04+35.6%
2017-01-20James B. RenacciBUY$1K–$15K$49.23$66.82 2026-09-04+35.7%
2017-01-20John HoevenSELL$50K–$100K$49.23$66.82 2026-09-04-35.7% exit
2016-08-22John HoevenBUY$50K–$100K$59.26$66.82 2026-09-04+12.8%
2016-08-18Sheldon WhitehouseSELL$1K–$15K$58.68$61.61 2026-10-26-5.0% exit
2016-08-17K. Michael ConawaySELL$1K–$15K$58.30$66.82 2026-09-04-14.6% exit
2016-08-11David A Perdue , JrBUY$1K–$15K$60.97$66.82 2026-09-04+9.6%
2016-08-08James M InhofeBUY$15K–$50K$60.30$66.82 2026-09-04+10.8%
2016-04-28James B. RenacciBUY$1K–$15K$72.26$66.82 2026-09-04-7.5%
2016-04-18Fred UptonBUY$1K–$15K$68.86$66.82 2026-09-04-3.0%
2016-03-22Fred UptonBUY$1K–$15K$62.80$66.82 2026-09-04+6.4%
2016-02-11Lamar SmithSELL$1K–$15K$59.52$66.82 2026-09-04-12.3% exit

Buys are marked to the latest close and treated as open. A sell tagged rt closes an earlier disclosed buy in the same name. exit shows how the stock moved after the member sold.

← PrevNext →

Frequently asked — Bristol-Myers Squibb Company (BMY) congressional trades

Which lawmakers have traded Bristol-Myers Squibb Company (BMY)?

37 members of the U.S. House and Senate have disclosed Bristol-Myers Squibb Company transactions under the STOCK Act — 78 purchases and 58 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.

Which lawmakers bought BMY recently?

No member of Congress has disclosed a BMY purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.

How have Congress's BMY trades performed?

Notional-weighted, lawmakers' disclosed BMY buys are up 28.6% versus the latest close of $66.82. Each trade's own return — and realized round-trips on matched sells — is in the Return column.

Is it legal for members of Congress to trade Bristol-Myers Squibb Company?

Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded BMY and how it performed.

Related stocks — also traded by the same lawmakers

MSFT 32AAPL 27JNJ 26AMZN 25PFE 25CSCO 25XOM 24DIS 24CVS 24CVX 24T 23MRK 23GE 22WFC 22GOOGL 22PG 22PEP 22CMCSA 22